Page last updated: 2024-10-15

carboxymethyl-beta-cyclodextrin

Cross-References

ID SourceID
PubMed CID131637431
MeSH IDM0407861

Synonyms (8)

Synonym
carboxymethyl-beta-cyclodextrin
218269-34-2
carboxymethyl-|a-cyclodextrin
carboxymethyl-| cent-cyclodextrin
D82976
mfcd30534340
carboxymethyl beta-cyclodextrin
AC-36712

Compound-Compound Interactions

ExcerptReference
"A high-performance and selective adsorbent was developed for simultaneous extraction of 6 chlorobenzenes residues in soil samples by using magnetic solid phase extraction (MSPE) combined with automated SPE followed by gas chromatography-mass spectrometry (GC-MS)."( β-cyclodextrin functionalized meso-/macroporous magnetic titanium dioxide adsorbent as extraction material combined with gas chromatography-mass spectrometry for the detection of chlorobenzenes in soil samples.
Cao, Y; Chen, S; Gan, N; Pan, M; Wu, D; Zhang, J, 2015
)

Bioavailability

ExcerptReference
"The objective of the present study was to evaluate the potential influence of carboxymethyl-beta-cyclodextrin (CM-beta-CyD) on the aqueous solubility, chemical stability and oral bioavailability of famotidine (FMT) as well as on its bitter taste."( Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
Abou-Taleb, AE; Anraku, M; Hirayama, F; Iohara, D; Khaled, KA; Mady, FM; Otagiri, M; Taguchi, K; Uekama, K; Yamasaki, K, 2010
)

Dosage Studied

ExcerptReference
" The method was applied to nine commercial CP preparations in six dosage forms and CP enantiomers were well separated without any disturbance of other ingredients or impurities present."( Enantioselective determination of chlorpheniramine in various formulations by HPLC using carboxymethyl-beta-cyclodextrin as a chiral additive.
Chen, QC; Hwang, GS; Jeong, SJ; Kang, JS; Kim, KH, 2008
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (29.11)29.6817
2010's47 (59.49)24.3611
2020's9 (11.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other81 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]